Freestone Capital Holdings, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 908 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.

Quarter-by-quarter ownership
Freestone Capital Holdings, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$482,715
-34.3%
4,739
-34.9%
0.03%
-13.3%
Q2 2023$735,129
-11.6%
7,285
-19.4%
0.03%
-18.9%
Q1 2023$831,864
-4.5%
9,042
-5.8%
0.04%
-7.5%
Q4 2022$871,093
-45.6%
9,602
-54.4%
0.04%
-44.4%
Q3 2022$1,602,000
-48.4%
21,072
-42.6%
0.07%
-39.5%
Q2 2022$3,105,000
-57.3%
36,727
-55.7%
0.12%
-59.4%
Q1 2022$7,279,000
+15.4%
82,956
+15.0%
0.29%
+9.7%
Q4 2021$6,309,000
+6.7%
72,122
-0.2%
0.27%
-9.8%
Q3 2021$5,912,000
-19.0%
72,292
-9.7%
0.30%
-19.1%
Q2 2021$7,302,000
+3.4%
80,031
-3.1%
0.37%
-4.7%
Q1 2021$7,059,000
-99.9%
82,579
+43.3%
0.38%
+20.8%
Q4 2020$5,442,190,000
-12.7%
57,632
-19.6%
0.32%
-21.7%
Q3 2020$6,232,075,000
+97658.0%
71,666
-1.8%
0.41%
+441.3%
Q2 2020$6,375,000
+13.5%
72,985
+7.1%
0.08%
-38.0%
Q1 2020$5,618,000
+40.6%
68,144
+61.5%
0.12%
+45.8%
Q4 2019$3,996,000
+22.1%
42,203
+12.1%
0.08%
+5.1%
Q3 2019$3,273,000
-0.5%
37,663
+4.6%
0.08%
-6.0%
Q2 2019$3,289,000
+16.7%
36,023
+22.9%
0.08%
-49.7%
Q1 2019$2,819,000
+36.0%
29,319
+21.4%
0.17%
+19.3%
Q4 2018$2,073,000
+43.2%
24,155
+43.7%
0.14%
+1455.6%
Q3 2018$1,448,000
+33.7%
16,804
+17.2%
0.01%
+28.6%
Q2 2018$1,083,000
+8.3%
14,334
+15.8%
0.01%
-87.9%
Q1 2018$1,000,000
-1.8%
12,374
+2.1%
0.06%
-18.3%
Q4 2017$1,018,000
+6.3%
12,123
+8.6%
0.07%
+4.4%
Q3 2017$958,000
+8.1%
11,159
+5.1%
0.07%
-1.4%
Q2 2017$886,000
+19.4%
10,618
+6.2%
0.07%
+21.1%
Q1 2017$742,000
+0.1%
9,997
-1.7%
0.06%
-10.9%
Q4 2016$741,000
-42.5%
10,175
-37.6%
0.06%
-45.8%
Q3 2016$1,288,000
-7.3%
16,316
-3.1%
0.12%
-13.2%
Q2 2016$1,389,000
+8.8%
16,831
-4.5%
0.14%
+1.5%
Q1 2016$1,277,000
-30.7%
17,623
-17.7%
0.13%
-29.8%
Q4 2015$1,842,000
+33.4%
21,410
+42.5%
0.19%
+27.3%
Q3 2015$1,381,000
+6.2%
15,029
+13.7%
0.15%
-27.5%
Q2 2015$1,300,000
-14.4%
13,216
-14.2%
0.21%
-13.4%
Q1 2015$1,519,000
-40.0%
15,404
-43.6%
0.24%
-42.8%
Q4 2014$2,532,000
-1.2%
27,330
+0.4%
0.42%
-5.6%
Q3 2014$2,563,000
-1.0%
27,232
-4.8%
0.44%
+9.4%
Q2 2014$2,590,000
-1.7%
28,613
-7.7%
0.40%
-13.3%
Q1 2014$2,635,000
-18.4%
30,994
-22.8%
0.47%
-18.4%
Q4 2013$3,228,000
+5.4%
40,156
+0.6%
0.57%
+5.0%
Q3 2013$3,062,000
+14.0%
39,921
+5.1%
0.54%
-1.1%
Q2 2013$2,686,00037,9850.55%
Other shareholders
NOVARTIS A G shareholders Q1 2017
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders